BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 21, 2026
Breaking News: BioWorld Science 2025 Year in Review
See today's BioWorld Science
Home
» ALKBH5-ERK1/2 identified as a new therapeutic axis in myopia
To read the full story,
subscribe
or
sign in
.
Ocular
ALKBH5-ERK1/2 identified as a new therapeutic axis in myopia
Feb. 9, 2026
No Comments
Myopia is a refractive disorder caused by excessive axial elongation, leading to blurred distance vision. Its development involves genetic, environmental and molecular factors, including retinal
N
6-methyladenosine (m6A) RNA modification.
BioWorld Science
Conferences
Ocular